DNA
Ginkgo Bioworks Holdings, Inc.
DNA
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks NYSE: DNA reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period, as the company continued to shift its focus toward autonomous laboratory systems,
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings Call Transcript